Published on in Vol 9 (2024)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/46974, first published .
Validation of a Novel Noninvasive Technology to Estimate Blood Oxygen Saturation Using Green Light: Observational Study

Validation of a Novel Noninvasive Technology to Estimate Blood Oxygen Saturation Using Green Light: Observational Study

Validation of a Novel Noninvasive Technology to Estimate Blood Oxygen Saturation Using Green Light: Observational Study

Original Paper

1Department of Biomedical Engineering, The University of Texas at Arlington, Arlington, TX, United States

2Shani Biotechnologies LLC, Austin, TX, United States

Corresponding Author:

Sanjay Gokhale, MD

Department of Biomedical Engineering

The University of Texas at Arlington

500 UTA Blvd

Arlington, TX, 76010

United States

Phone: 1 8172645227

Email: rajhanssanjay@gmail.com


Background: Pulse oximeters work within the red-infrared wavelengths. Therefore, these oximeters produce erratic results in dark-skinned subjects and in subjects with cold extremities. Pulse oximetry is routinely performed in patients with fever; however, an elevation in body temperature decreases the affinity of hemoglobin for oxygen, causing a drop in oxygen saturation or oxyhemoglobin concentrations.

Objective: We aimed to determine whether our new investigational device, the Shani device or SH1 (US Patent 11191460), detects a drop in oxygen saturation or a decrease in oxyhemoglobin concentrations.

Methods: An observational study (phase 1) was performed in two separate groups to validate measurements of hemoglobin and oxygen concentrations, including 39 participants recruited among current university students and staff aged 20-40 years. All volunteers completed baseline readings using the SH1 device and the commercially available Food and Drug Administration–approved pulse oximeter Masimo. SH1 uses two light-emitting diodes in which the emitted wavelengths match with absorption peaks of oxyhemoglobin (hemoglobin combined with oxygen) and deoxyhemoglobin (hemoglobin without oxygen or reduced hemoglobin). Total hemoglobin was calculated as the sum of oxyhemoglobin and deoxyhemoglobin. Subsequently, 16 subjects completed the “heat jacket study” and the others completed the “blood donation study.” Masimo was consistently used on the finger for comparison. The melanin level was accounted for using the von Luschan skin color scale (VLS) and a specifically designed algorithm. We here focus on the results of the heat jacket study, in which the subject wore a double-layered heated jacket and pair of trousers including a network of polythene tubules along with an inlet and outlet. Warm water was circulated to increase the body temperature by 0.5-0.8 °C above the baseline body temperature. We expected a slight drop in oxyhemoglobin concentrations in the heating phase at the tissue level.

Results: The mean age of the participants was 24.1 (SD 0.8) years. The skin tone varied from 12 to 36 on the VLS, representing a uniform distribution with one-third of the participants having fair skin, brown skin, and dark skin, respectively. Using a specific algorithm and software, the reflection ratio for oxyhemoglobin was displayed on the screen of the device along with direct hemoglobin values. The SH1 device picked up more minor changes in oxyhemoglobin levels after a change in body temperature compared to the pulse oximeter, with a maximum drop in oxyhemoglobin concentration detected of 6.5% and 2.54%, respectively.

Conclusions: Our new investigational device SH1 measures oxygen saturation at the tissue level by reflectance spectroscopy using green wavelengths. This device fared well regardless of skin color. This device can thus eliminate racial disparity in these key biomarker assessments. Moreover, since the light is shone on the wrist, SH1 can be readily miniaturized into a wearable device.

JMIR Biomed Eng 2024;9:e46974

doi:10.2196/46974

Keywords



Pulse oximetry is routinely performed in all patients with elevated body temperature. However, high blood temperature decreases the affinity of oxygen for hemoglobin (Hb) [1], and an elevation in temperature by approximately 1 °C decreases arterial oxygen saturation (sO2) by only 0.5% [2]. Therefore, the decrease is very minimal and is not clinically significant in subjects with a baseline sO2 level within the normal range [3].

Blood sO2 measured by pulse oximetry is currently used to monitor tissue hypoxia. This method uses red and infrared wavelengths in the light spectrum and there is no correction for the level of skin melanin. Consequently, the estimated values are often inaccurate in people with darker skin tones due to the overlapping absorption spectra of melanin [4,5]. Administrative and health authorities have also recognized this issue; however, a solution has not yet been put forward [6].

To overcome this limitation, we have developed a novel technology to estimate Hb and tissue oxygenation. The scientific basis, details, and underlying technology of the device are published elsewhere [7]. In brief, the Shani device (SH1) measures reflectance of light from the skin by a pair of light-emitting diodes (LEDs), displayed as the reflectance ratio from LED1 (E1) and LED2 (E2) and as the sum of the ratios (E; E1+E2). The method of measurement is described in our previous report [7]. The light is shone on the wrist and only the reflected light is picked up by the sensors. This analog signal is then converted to a digital format by the processor, which can be analyzed, displayed, and stored in digital form (US Patent 11191460). In this device and associated technology, the reflectance ratio varies inversely with the concentration of Hb or Hb combined with oxygen (OxyHb) [8].

With an increase in body temperature, a slight drop in OxyHb is expected. Here, we focus on the results of the phase 1 study (heat jacket study) to validate the device in healthy human volunteers. The body temperature of the participants was increased by circulating warm water in a double-layered heat jacket; therefore, a slight drop in the OxyHb concentration at the tissue level was expected during the heating phase. The aim of this study was to determine whether our new device can detect the drop in sO2 or a decrease in tissue OxyHb concentrations.


Investigational Device

The SH1 device was validated in tissue phantom experiments. Here, we are presenting the results of the phase 1 heat jacket study in healthy human volunteers. Details of preclinical studies and the results of these experiments have been recently published elsewhere [9]. In the preclinical experiments, we used synthetic melanin as an epilayer mimicking melanin and we used horse blood in the lower layer corresponding to the dermis of the skin. As a part of preclinical studies, we performed an absorption scan of synthetic melanin (Sigma-Aldrich, Instrument-Infinite 200 and BME089922 software system). At a melanin concentration of 1.5 mg/ml, the absorption coefficient of melanin (ie, the absorption of light per unit length) was determined to be 4.01/ml. Even with this high melanin concentration in the epilayer, our device could detect changes in OxyHb levels in the lower dermal layer. Dark-skinned subjects showed an absorption coefficient of melanin at 550 nm, corresponding to 2.5/ml. Therefore, in this preclinical study, we tested melanin levels that are higher (darker) than those measured for dark-skinned subjects. The relationship of melanin concentration with the absorption coefficient of melanin at a wavelength of 550 nm was determined in the previous study [9]. This new investigational device (SH1) measures Hb by shining light from LED1 and LED2 sequentially to obtain measures of both OxyHb and reduced Hb (ie, DeoxyHb). This is termed the “hemoglobin mode” of the operation. The reflectance ratio for LED1 is referred to as E1 and that for LED2 is referred to as E2. The reflectance ratio E1 corresponds to OxyHb, which is inversely related to the oxygen content (Figure 1). The device could detect changes in oxygen concentration in the blood, even in the presence of high melanin in the epilayer, thereby mimicking the detection of hypoxia in dark-skinned subjects.

Figure 1. Results (left) and setup (right) of the tissue phantom experiment [9]. The graph shows the relationship between the reflectance ratio of light-emitting diode 1 (E1) with the measured oxygen saturation level (%). The epilayer or upper cup contained 1.503 mg/ml melanin, corresponding to a coefficient of melanin absorption (at 550 nm) of 4.01/cm. This figure was adapted from Gokhale et al [9] which is published under Creative Commons Attribution 4.0 International License [10].

Eligibility and Recruitment

As per the institutional policy, only current students and members of the staff of University of Texas at Arlington were recruited for this validation study. External candidates, including past students, were not allowed to participate. The age restriction for participation was 20-40 years. For recruitment, flyers were sent by email and posters were displayed in designated locations, including the lobby, near elevators, the cafeteria, and common rooms.

The phase 1 study was performed with two separate cohorts independently for validation of measurements of Hb and oxygen concentrations. There were 39 participants in the two studies; there was only one staff member and the remaining participants were students. Both studies included baseline measurements at visit 1. All 39 volunteers completed baseline readings using our new investigational SH1 device. Subsequently, 16 participants completed the heat jacket study and the others were included in the blood donation study. The commercially available pulse oximeter Masimo was used on the finger for comparison. Skin melanin was accounted for using the von Luschan skin color scale (VLS) and a specifically designed algorithm. Skin tone measurements were performed by two observers independently and the mean value was noted and rounded to the nearest integer. We here focus only on the results of the heat jacket study.

Ethical Considerations

The heat jacket study was approved by the institutional review board (IRB) at The University of Texas at Arlington (STU-2021-0150; approval date February 23, 2021). Written informed consent was obtained from each participant. Copies of consent forms are maintained by IRB authorities. The privacy and confidentiality of the participants were respected and data are stored in a coded, anonymous format. Each participant received monetary compensation as per the stipulated rules and regulations laid out by the IRB of The University of Texas at Arlington.

Study Design

The heat jacket study included 16 volunteers and was performed under the IRB-approved protocol. At visit 1, baseline measurements of Hb and oxygen concentrations were taken using our novel SH1 device and the commercial pulse oximeter Masimo. At visit 2, after obtaining appropriate consent, the baseline demographic information was obtained. The participant was then asked to wear a double-layered heat jacket and a pair of trousers, which comprise a network of polythene tubules and an inlet and outlet. Subsequently, the participant swallowed a telemetry pill with some water; this is a small pill-shaped electronic object that is used to sense temperature. After a few minutes, the pill reaches the stomach, measures internal body temperature, and emits a signal. A sensor attached to the jacket receives these signals, which are then relayed to a monitor via a cable. Baseline readings were taken with the participant lying down. Warm water was circulated in the jacket and trousers to increase the body temperature by 0.5-0.8 °C above the baseline body temperature as measured with the telemetry pill. This increase in body temperature simulates clinically relevant fever settings. The heating phase lasted for 40 minutes, followed by cooling for the next 20 minutes. Cooling was achieved by circulating cold water through the jacket. Baseline and serial readings were taken with the new investigational SH1 device at 10-minute intervals. The measurements taken with the Masimo Pronto pulse oximeter were used for comparison. A total of 7 sets of observations were obtained for each participant over a period of 60 minutes. Readings in the heating phase and cooling phase were rescaled for each participant with baseline measurements taken as 100%. The percentage drop in sO2 or the difference between maximum and minimum readings by the SH1 and Masimo devices was plotted for each participant.


The mean age of the study population was 24.1 (SD 0.8) years. The skin tone varied from 12 to 36 on the VLS with a uniform distribution: one-third of the participants had fair skin, brown skin, and dark skin, respectively. Using a specific algorithm accounting for melanin, as determined from the VLS, and associated software, the reflection ratio for OxyHb is displayed on the screen along with direct Hb values [11]. We had baseline readings for all 39 participants (Figure 2) with our SH1 device and the commercial pulse oximeter Masimo. As seen in Figure 2, baseline oxygen concentrations of all 39 participants as measured by SH1 device readings fell within a range similar to those measured by the pulse oximeter.

In the heat jacket study, we expected a slight drop in OxyHb concentrations in the heating phase at the tissue level. Our hypothesis was confirmed after analyzing the data for the reflection ratios E1, E2, and E (E1+E2), followed by computation of OxyHb and total Hb values. Figure 3 shows the distribution of the skin tone (according to the VLS) of the participants compared to the percentage drop in oxygen concentrations in the 16 subjects participating in the heat jacket study. Our device could pick up more minor changes in OxyHb levels after a change in body temperature than possible with the pulse oximeter. The maximum drop in OxyHb concentrations picked up by our device was 6.5% compared to a drop of only 2.54% sensed by the pulse oximeter. The average change in OxyHb measured by our device was 2.98%, whereas that of the pulse oximeter was 1.33%, with a median of 3% and 1%, respectively.

Figure 2. Skin tone versus oxygen saturation measured by the Shani device and Masimo pulse oximeter at baseline in all 39 participants. VLS: von Luschan skin coloration scale.
Figure 3. Skin tone versus the percentage drop in oxygen concentrations for the 16 participants in the heat jacket study, as measured by the new device and the commercial pulse oximeter Masimo. VLS: von Luschan skin color scale.

Principal Findings

The baseline readings taken by the SH1 device (Figure 2) while the participants were lying in supine position showed some interesting features, including different readings for subjects with the same skin tone (eg, subjects with skin tones 15, 16, 22, and 26 on the VLS) and similar readings for subjects with different skin tones (eg, subjects with skin tones 15, 16, and 26 on the VLS). Therefore, the baseline measurement of tissue oxygen levels (ie, OxyHb levels) as determined by the SH1 device is independent of skin tone and likely depends on tissue metabolism and the basal metabolic rate.

In this heat jacket study, all participants showed a drop in OxyHb levels during the heating phase, followed by a rise in the cooling phase. In some cases, the rise was slightly higher than baseline levels.

We compared the difference in maximum and minimum readings obtained by our SH1 device and the commercial pulse oximeter Masimo. Figure 3 shows the distribution of the difference across different skin tones. This drop in oxygen saturation was magnified by the SH1 device compared to the readings obtained with the pulse oximeter. The difference between maximum and minimum readings by the SH1 device was 6.5%, whereas that for Masimo was only 2.54%.

As stated earlier, the decrease in arterial oxygen levels with fever is very small, even in patients in the intensive care unit, and this drop in sO2 is not clinically significant in patients with baseline sO2 within the normal range. Nonetheless, this minor change is picked up well by our device and is not detected by the pulse oximeter. The commercial pulse oximeter Masimo Pronto measures arterial sO2 by photoplethysmography and red-infrared wavelengths [12], whereas the novel SH1 device measures sO2 at the tissue level by reflectance spectroscopy and using two green wavelengths. These are two important fundamental differences between these technologies. Table 1 compares the properties of the SH1 device and pulse oximeter.

Table 1. Comparison of the properties of the new investigational device (Shani device) and a conventional pulse oximeter.
PropertiesPulse oximeterShani device
Radiation usedRed and infrared wavelengthsGreen visible light
MethodTransmittance of lightReflectance of light
Any solution for melanin interference?None so farYes; accounted for using a special algorithm
Accuracy of O2% in dark-skinned subjects?Doubtful; erratic results are obtained with darker skin tonesHigh accuracy in all subjects, regardless of skin color
Diagnostic ability (eg, hypotension, shock)Poor accuracyHigh accuracy
Continuous monitoring possibleYesYes
Site of testingFingertipBack of wrist
Can be transitioned into a wearable?UnclearCertainly
Data storage and transferYesYes
Battery operatedYesYes

Working of the Device

The emitted wavelengths of the two LEDs matched with the absorption peaks of OxyHb and DeoxyHb (ie, reduced Hb) between 520 nm and 580 nm. As mentioned above, in our new device, the input from LED1 and LED2 of the probe is received as an analog signal. This signal is then converted to digital format by the processor, which can be analyzed, displayed, and stored in digital form. In tissue phantom experiments, we bubbled air and measured the increase in oxygen concentrations in horse blood using an oxygen sensor [9]. The reflection ratio E1 received from LED1 correlates inversely with OxyHb, E2 from LED2 correlates with DeoxyHb, and E (sum of E1 and E2) correlates with total Hb. After analyzing data from the tissue phantom experiments, we derived another new parameter termed the “OxyHb index” as a measure of OxyHb concentration. In our earlier tissue phantom experiments [9], we found that this OxyHb index varies directly with the oxygen concentration in the blood (Figure 4). This means that low oxygen concentrations are reflected as a low OxyHb index and vice versa.

Tissue oxygenation parameters include the concentrations of Hb and OxyHb in the tissue [13]. Tissue sO2 monitoring is a relatively new technology, and a drop in tissue sO2 is an early warning sign of peripheral hypoperfusion and the onset of tissue hypoxia [14]. All oximeters currently available using red and infrared wavelengths to target arterial blood flow, which measures sO2 in the conducting vascular/arterial system. Our device targets the capillary-venous network and measures tissue oxygenation. Sepsis and shock result in disturbances in microcirculatory perfusion and a change in tissue oxygen utilization that may not be reflected in arterial sO2 levels. According to many authorities, tissue oxygenation is a better marker of the underlying pathological processes as well as responsiveness to some treatments [15,16]. Tissue oxygen levels are more important, because the arterial O2 content and an adequate bulk transport of oxygen by the cardiovascular system may not guarantee delivery of oxygen to the critical tissues of the body [17]. Additionally, tissue Hb sO2 has been determined to be a better predictor of the multiorgan failure outcome [18]. Near-infrared spectroscopy also has well-known limitations [19]. To overcome these limitations, our new device uses green light (520-570 nm) for the estimation of Hb and OxyHb, while accounting for the impact of skin color on the measurements. A summary presentation displays relevant information about this technology in Multimedia Appendices 1 and 2. The video demonstrates the working of this new device.

Using green wavelengths for measurements of Hb and oxygen concentrations with a special algorithm to account for melanin is a novel concept and our efforts have already been appreciated by experts in the field [20,21]. In this study, we have used the VLS for the measurements of skin tone. This is an interval scale with measurements such as 18, 23, and 36. However, we are developing a technology to quantify melanin in the skin more precisely in a noninvasive manner, providing measurements on a continuous scale (eg, 15.25, 17.50, and 30.75). This method is patented and under development.

Figure 4. Oxygen concentrations (%) versus the oxyhemoglobin index.

Strengths and Limitations

The main limitation of this study is the small sample size. Although our device fared better than the pulse oximeter, larger studies are needed in patients with diverse skin tones and a variable degree of tissue hypoxia for further clinical development of the device.

The main strength of this study is that the SH1 device offers an early warning system. A drop in tissue sO2 is an early warning sign of peripheral hypoperfusion and the onset of tissue hypoxia. Our device can sense this before traditional oximeters can raise the alarm, thereby demonstrating the potential for saving lives.

Our device can also be used in diverse settings, from home monitoring to intensive care, making critical data readily available. Light is shone on the wrist of the individual and is then measured. Therefore, in the future, this device can be miniaturized for wearable technology. The device can be operated in either hemoglobin or oximetry mode. In hemoglobin mode, the device can be used for noninvasive measurements of Hb, whereas in oximetry mode, the device can be used for the continuous monitoring of sO2.

Racial equity is another important advantage of our device. Unlike most pulse oximeters on the market, our device works for all skin tones, eliminating bias and improving care for people of color.

The specific technology underlying the design of our device offers specific advantages. First, the use of green light (520-570 nm) can obtain information from the microcirculation, revealing tissue oxygen levels invisible to red and infrared wavelengths of light. Second, our unique algorithm accounts for variations in melanin, ensuring accurate readings. These advantages can consequently lead to improved outcomes, as early detection and tailored therapies lead to better health for all, especially marginalized groups. Moreover, the ability to obtain a faster diagnosis and intervention can save both resources and lives. Finally, the device offers global reach as it is affordable and adaptable, thereby demonstrating potential to improve health care in resource-limited settings.

Conclusion

The changes in sO2 at the tissue level in normoxemic subjects are very minor or minimal. Current pulse oximeters, limited to red and infrared wavelengths, only capture the “big picture” of arterial blood flow by measuring oxygen saturation in the conducting arterial system while missing critical changes in the microcirculation, where sepsis and shock wreak havoc, before the arterial oxygen dips.

Our device is a game-changer for measuring tissue oxygenation by shining green light and offering a more sensitive marker of these hidden dangers. Our device was validated to accurately measure tissue oxygen levels and could pick up very minor changes after a change in body temperature in the heat jacket study, demonstrating improved performance compared to the commercial pulse oximeter. Tissue oxygenation parameters include the concentrations of Hb and OxyHb in the tissue. Our device worked better and appeared to be more sensitive than the pulse oximeter even for subjects with light skin or skin tone (eg, VLS 12-18). Since the sample size of this study was small, additional studies with large sample size, a diverse population, and varied degree of hypoxia are required for further confirmation.

Acknowledgments

We thank Dr Michael Nelson, Associate Professor, Department of Kinesiology, University of Texas at Arlington for allowing the use of the Kinesiology Laboratory for the clinical study. The project was funded by Shani Biotechnologies (to GA).

Data Availability

Since this is a patented technology, the data cannot be widely shared. However, the data are available with the institutional review board of the University of Texas at Arlington and can be accessed through Shani Biotechnologies LLC after completing nondisclosure agreement or confidential disclosure agreement formalities.

Authors' Contributions

SGG and GA contributed to the conceptualization, formal analysis, and methodology. VD and GA acquired the funding. GA contributed to project administration and supervision. All authors wrote the original draft and reviewed and edited the manuscript.

Conflicts of Interest

None declared.

Multimedia Appendix 1

Summary Presentation

PPTX File , 5624 KB

Multimedia Appendix 2

Shani Biotech Demo(10mb)

MP4 File (MP4 Video), 9402 KB

  1. Goldberg S, Heitner S, Mimouni F, Joseph L, Bromiker R, Picard E. The influence of reducing fever on blood oxygen saturation in children. Eur J Pediatr. Jan 2018;177(1):95-99. [CrossRef] [Medline]
  2. Kiekkas P, Brokalaki H, Manolis E, Askotiri P, Karga M, Baltopoulos GI. Fever and standard monitoring parameters of ICU patients: a descriptive study. Intensive Crit Care Nurs. Oct 2007;23(5):281-288. [CrossRef] [Medline]
  3. Lahav DZ, Picard E, Mimouni F, Joseph L, Goldberg S. The effect of fever on blood oxygen saturation in children. Harefuah. Mar 2015;154(3):162-165, 213, 212. [Medline]
  4. Fawzy A, Wu TD, Wang K, Robinson ML, Farha J, Bradke A, et al. Racial and ethnic discrepancy in pulse oximetry and delayed identification of treatment eligibility among patients with COVID-19. JAMA Intern Med. Jul 01, 2022;182(7):730-738. [FREE Full text] [CrossRef] [Medline]
  5. Zonios G, Bykowski J, Kollias N. Skin melanin, hemoglobin, and light scattering properties can be quantitatively assessed in vivo using diffuse reflectance spectroscopy. J Invest Dermatol. Dec 2001;117(6):1452-1457. [FREE Full text] [CrossRef] [Medline]
  6. Pulse oximeter accuracy and limitations: FDA Safety Communication. US Food and Drug Administration. URL: https:/​/www.​fda.gov/​medical-devices/​safety-communications/​pulse-oximeter-accuracy-and-limitations-fda-safety-communication [accessed 2024-03-11]
  7. Gokhale SG, Daggubati V, Alexandrakis G. Innovative technology to eliminate the racial bias in non-invasive, point-of-care (POC) haemoglobin and pulse oximetry measurements. BMJ Innov. Sep 26, 2022;9(2):73-77. [CrossRef]
  8. Jacques SL. Quick analysis of optical spectra to quantify epidermal melanin and papillary dermal blood content of skin. J Biophotonics. Apr 2015;8(4):309-316. [CrossRef] [Medline]
  9. Gokhale SG, Daggubati VS, Alexandrakis G. Developing a novel device based on a new technology for non-invasive measurement of blood biomarkers irrespective of skin color. Ger Med Sci. 2023;21:Doc09. [FREE Full text] [CrossRef] [Medline]
  10. Attribution 4.0 International (CC BY 4.0). Creative Commons. URL: https://creativecommons.org/licenses/by/4.0/ [accessed 2024-03-22]
  11. Swiatoniowski AK, Quillen EE, Shriver MD, Jablonski NG. Technical note: comparing von Luschan skin color tiles and modern spectrophotometry for measuring human skin pigmentation. Am J Phys Anthropol. Jun 2013;151(2):325-330. [CrossRef] [Medline]
  12. Nitzan M, Romem A, Koppel R. Pulse oximetry: fundamentals and technology update. Med Devices. 2014;7:231-239. [FREE Full text] [CrossRef] [Medline]
  13. Teng Y, Ding H, Huang L, Li Y, Shan Q, Ye D, et al. Non-invasive measurement and validation of tissue oxygen saturation covered with overlying tissues. Prog Nat Sci. Sep 2008;18(9):1083-1088. [CrossRef]
  14. Epstein CD, Haghenbeck KT. Bedside assessment of tissue oxygen saturation monitoring in critically ill adults: an integrative review of the literature. Crit Care Res Pract. 2014;2014:709683. [CrossRef] [Medline]
  15. Jones N, Terblanche M. Tissue saturation measurement--exciting prospects, but standardisation and reference data still needed. Crit Care. 2010;14(3):169. [FREE Full text] [CrossRef] [Medline]
  16. Swartz HM, Flood AB, Schaner PE, Halpern H, Williams BB, Pogue BW, et al. How best to interpret measures of levels of oxygen in tissues to make them effective clinical tools for care of patients with cancer and other oxygen-dependent pathologies. Physiol Rep. Aug 2020;8(15):e14541. [FREE Full text] [CrossRef] [Medline]
  17. Dantzker DR. Monitoring tissue oxygenation. The search for the grail. Chest. Jan 1997;111(1):12-14. [CrossRef] [Medline]
  18. Santora RJ, Moore FA. Monitoring trauma and intensive care unit resuscitation with tissue hemoglobin oxygen saturation. Crit Care. 2009;13(Suppl 5):S10. [FREE Full text] [CrossRef] [Medline]
  19. Scheeren TWL, Schober P, Schwarte LA. Monitoring tissue oxygenation by near infrared spectroscopy (NIRS): background and current applications. J Clin Monit Comput. Aug 2012;26(4):279-287. [FREE Full text] [CrossRef] [Medline]
  20. Yang B, Moss J. Evolution of the Pulse Ox. Chest. Jul 2023;164(1):24-26. [FREE Full text] [CrossRef] [Medline]
  21. Updating pulse oximeters. National Heart, Lung and Blood Institute. Jul 2023. URL: https://www.nhlbi.nih.gov/news/2023/updating-pulse-oximeters [accessed 2024-03-11]


DeoxyHb: deoxyhemoglobin
Hb: hemoglobin
IRB: institutional review board
LED: light-emitting diode
OxyHb: oxyhemoglobin
SH1: Shani device
sO2: oxygen saturation
VLS: von Luschan skin color scale


Edited by T Leung; submitted 03.03.23; peer-reviewed by J Spigulis, MS Arefin; comments to author 11.07.23; revised version received 21.07.23; accepted 29.02.24; published 27.03.24.

Copyright

©Sanjay Gokhale, Vinoop Daggubati, Georgios Alexandrakis. Originally published in JMIR Biomedical Engineering (http://biomsedeng.jmir.org), 27.03.2024.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Biomedical Engineering, is properly cited. The complete bibliographic information, a link to the original publication on https://biomedeng.jmir.org/, as well as this copyright and license information must be included.